NCT00622258已完成1 期
A Phase I Dose Escalation Study of RAD001 Administered in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
适应症
干预措施
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 13
- 试验地点
- 1
- 主要终点
- To assess the pharmacokinetics in Japanese patients
研究概览
简要总结
This study assesses the tolerability, safety, efficacy and pharmacokinetics of everolimus in Japanese patients. Everolimus is administered orally everyday to adult patients with relapsed or refractory non-Hodgkin's lymphoma who have progressed despite standard therapy or for whom standard systemic therapy dose not exist.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 20 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
Everolimus
Experimental
干预措施: Everolmus (Drug)
结局指标
主要结局
To assess the pharmacokinetics in Japanese patients
时间窗: 1st sycle
To assess the safety and tolerability of RAD001 in Japanese patients with relapsed or refractory non-Hodgkin's lymphoma
时间窗: whole study period
次要结局
- To seek preliminary evidence of efficacy in this population(Every 2 cycles)
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
1 期
Everolimus (RAD001) in Elderly Patients With Acute Myeloid LeukemiaAcute Myeloid LeukemiaNCT00636922Bayside Health40
已完成
2 期
Everolimus (RAD001) in Primary Therapy of Waldenstrom's MacroglobulinemiaWaldenstrom's MacroglobulinemiaNCT00976248Dana-Farber Cancer Institute33
已完成
2 期
Efficacy and Safety of Everolimus (RAD001) in Patients With Advanced Gastric CancerAdvanced Gastric CancerNCT00519324Novartis Pharmaceuticals54
Unknown
1 期
Everolimus (RAD001) and Carboplatin in Pretreated Metastatic Breast CancerBreast CancerNCT00930475Charite University, Berlin, Germany54
已完成
1 期
Single Ascending Dose Study to Assess the Safety, Tolerability, PK and PD of ONO-4685 in Japanese and Caucasian Healthy Adult Male SubjectsHealthy VolunteersNCT04079062Ono Pharmaceutical Co. Ltd78